Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01017003 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetic Study With Colchicine in Healthy Volunteers
A Phase 1 study, sponsored by Mutual Pharmaceutical Company.
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT01017003 is a Phase 1 study that has completed, run by Mutual Pharmaceutical Company. The registered enrollment target is 14 participants.
The verdict
NCT01017003, a Phase 1 study, has completed, sponsored by Mutual Pharmaceutical Company.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
This open label, single group, sequential dose study will compare the single dose pharmacokinetics of colchicine 0.6 mg given orally to colchicine pharmacokinetics after 10 days of a standard prophylactic dose (0.6 mg every 12 hours) in healthy volunteers.
Interventions
- DRUG colchicine tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2007-09 |
| Est. Completion | 2007-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01017003
The ClinicalTrials.gov registry entry for NCT01017003 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mutual Pharmaceutical Company, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which colchicine tablets is the first listed.
NCT01017003 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01017003 about?
NCT01017003 is a clinical study titled "Pharmacokinetic Study With Colchicine in Healthy Volunteers". This open label, single group, sequential dose study will compare the single dose pharmacokinetics of colchicine 0.6 mg given orally to colchicine pharmacokinetics after 10 days of a standard prophylactic dose (0.6 mg every 12 hours) in healthy volunteers.
What is the current status of trial NCT01017003?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2007-09. Estimated completion is 2007-12.
What interventions are being tested in trial NCT01017003?
The interventions under investigation include: colchicine tablets (DRUG).
Who is sponsoring clinical trial NCT01017003?
This trial is sponsored by Mutual Pharmaceutical Company, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.